Seeyond’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Seeyond's DGX Position: Q4 2022 in Review
Seeyond increased its Quest Diagnostics (DGX) stake by 4.2% in Q4 2022, buying an estimated $191K and bringing the position to 33,065 shares worth $5.17M. The position accounts for 0.5% of the portfolio, ranked #39.
Seeyond first reported a position in DGX in Q4 2018 and has held it in 17 quarters since. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.
- Seeyond held 33,065 shares of Quest Diagnostics worth $5.17M as of Q4 2022.
- Seeyond bought 1,326 Quest Diagnostics shares in Q4 2022, an estimated $191K.
- Quest Diagnostics made up 0.5% of Seeyond's portfolio in Q4 2022, its #39 holding.
- Seeyond first reported a position in Quest Diagnostics in Q4 2018 and has held it in 17 quarters since.
- 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.
Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.